The FDA has permitted two artificial formulations of THC for treating particular circumstances: nabilone and dronabinol.THC targets receptors within a fashion significantly less selective than endocannabinoid molecules, and its pharmacodynamic tolerance may limit maximal effects of sure medicines although maximizing the drug's therapeutic window.Be